As broader market indices like sensex and nifty continue to form new highs. Some stocks have witnessed consistent improvement in their scor...

Rutendo Kuwana from the WHO on October 13 had written to the DCGI seeking to know the progress with the investigation of the manufacturer o...

As reported by ET on Wednesday, a preliminary report revealed that several violations have been found at the facility. It said that in rela...

The development comes on a day the Haryana government ordered the halting of drug manufacturing at the Sonipat unit of Maiden Pharmaceutica...

India's health and welfare ministry said Thursday that Maiden Pharmaceuticals had the license to only export four drugs that are now linked...

A probe has already been initiated by India's drug regulator, the Drugs Controller General of India. "The samples have been collected by a ...

Among the stock-specific action, Nureca, Cybertech Systems and India Glycols hit their upper circuits of 20 per cent each. Manaksia Aluminu...

The chemicals maker is betting big on its liquor and nutraceuticals businesses, as well as other value-added specialty chemicals.

The commodity chemical company reported a 296 per cent jump in consolidated profit to Rs 70.99 crore in the March 2021 quarter, as against ...

'India Glycols Ltd is a 'BUY' call with a target of Rs 124 and a stop loss of Rs 108.'

'India Glycols Ltd is a 'BUY' call with a target of Rs 126 and a stop loss of Rs 105.'

India Glycol Ltd is a 'BUY' call with a target of Rs 148 and a stop loss of Rs 131.

India Glycols Ltd is a 'BUY' call with a target of Rs 142 and a stop loss of Rs 125.

India Glycols Ltd is a ‘BUY’ call with a target of Rs 207 and a stop loss of Rs 187.

India Glycols is a ‘BUY’ call with a target of Rs 163 and a stop loss of Rs 147.

India Glycols Ltd is a ‘BUY’ call with a target of Rs 168 and a stop loss of Rs 145.

Anand Rathi Financial Services has recommended 'strong buy' on India Glycols for target price ranging between Rs 400-500.